Predictably, Solazyme has filed for an initial public offering (IPO), targeting $100 million. Why was it predictable? Because just as Amyris bolstered its business with multiple strong partnerships in the months...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)